KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway

Rok, strany: 2018, 81 - 88

Oncogenic Kras with loss of heterozygosity (LOH) is frequently detected in various tumours. However, the exact function and mechanism by which KrasG12D-LOH operates remain unclear. Therefore, the current study investigated the effect of KrasG12D-LOH on the malignant phenotype of pancreatic ductal adenocarcinoma (PDAC) cells. Our investigation revealed that KrasG12D-LOH is associated with increased proliferation, invasion and reduced apoptosis in PDAC cells. The results also exhibited the enhanced glycolytic phenotype of KrasG12D-LOH PDAC cells. Hyperactive mTOR plays a significant role in the initiation and maintenance of tumors. To investigate the correlation between KrasG12D-LOH and mTOR, the mTOR signaling pathway was detected by western blot analysis. We found that KrasG12D-LOH up-regulated Akt, AMPK, REDD1 and mTOR in PDAC cells. In summary, our results demonstrated that KrasG12D-LOH promotes oncogenic Kras-induced PDAC by regulating energy metabolism and the mTOR signaling pathway. These data may provide novel therapeutic perspectives for PDAC.

ISO 690:

Shen, X., Chang, L., Hu, M., Yan, D., Zhou, L., Ma, Y., Ling, S., Fu, Y., Zhang, S., Kong, B., Huang, P. 2018. KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway. In NEOPLASMA, vol. 65, no.1, pp. 81-88. 0028-2685.

APA:

Shen, X., Chang, L., Hu, M., Yan, D., Zhou, L., Ma, Y., Ling, S., Fu, Y., Zhang, S., Kong, B., Huang, P. (2018). KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway. NEOPLASMA, 65(1), 81-88. 0028-2685.